No. of patients (%) stratified by NLR | |||
---|---|---|---|
Characteristic | ≤ 2.50 (n = 813) | > 2.50 (n = 737) | P value |
Age | 0.222 | ||
≤ 45 | 404 (49.7) | 343 (46.6) | |
> 45 | 409 (50.3) | 394 (53.4) | |
Sex | 0.034 | ||
Male | 575 (70.7) | 557 (75.6) | |
Female | 238 (29.3) | 180 (24.4) | |
T stage | 0.001 | ||
T1 | 110 (13.5) | 80 (10.9) | |
T2 | 151 (18.6) | 114 (15.5) | |
T3 | 418 (51.4) | 378 (51.3) | |
T4 | 134 (16.5) | 165 (22.4) | |
N stage | 0.015 | ||
N0 | 106 (13.0) | 84 (11.4) | |
N1 | 485 (59.7) | 443 (60.1) | |
N2 | 132 (16.2) | 94 (12.8) | |
N3 | 90 (11.1) | 116 (15.7) | |
Overall stage | < 0.001 | ||
II | 189 (10.9) | 143 (19.4) | |
III | 316 (38.9) | 341 (46.3) | |
IVA-B | 396 (48.7) | 253 (34.3) | |
Family history | 0.574 | ||
No | 575 (70.7) | 531 (72.0) | |
Yes | 238 (29.3) | 206 (28.0) | |
Smoking history | 0.402 | ||
No | 496 (61.0) | 465 (63.1) | |
Yes | 317 (39.0) | 272 (36.9) | |
Drinking history | 0.247 | ||
No | 720 (88.6) | 638 (86.6) | |
Yes | 93 (11.4) | 99 (13.4) | |
Treatment strategy | 0.779 | ||
RT | 89 (10.9) | 76 (10.3) | |
CCRT alone | 316 (38.9) | 278 (37.7) | |
NACT+CCRT | 408 (50.2) | 383 (52.0) |